Estimated longevity benefit: +1.3 years. Evidence score: 46/100.
Naturally occurring weak estrogen with very low feminizing activity that extended median lifespan by +19% in male mice in the NIA ITP — one of the most sex-specific longevity findings ever documented. Zero effect in females across all doses and cohorts.